Jump to content

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib (Q21563446)

From Wikidata
scientific article
  • KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib
edit
Language Label Description Also known as
default for all languages
No label defined
    English
    KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib
    scientific article
    • KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib

    Statements

    KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib (English)
    January 2005
    0 references
    2
    0 references
    1
    0 references
    e17
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit